Learn about BYETTA, the BYETTA Pen. in patients with prior severe hypersensitivity reactions to exenatide or to any of the product components. Patient Information Leaflet. Package leaflet: Information for the patient. Byetta 5 micrograms solution for injection in pre-filled pen. Byetta 10 micrograms solution . Easy to read FDA package insert, drug facts, dosage and administration, and adverse effects for Byetta (Exenatide).
|Published (Last):||27 July 2007|
|PDF File Size:||7.20 Mb|
|ePub File Size:||16.49 Mb|
|Price:||Free* [*Free Regsitration Required]|
No placebo-treated patients withdrew due to byetta package insert or vomiting. You may byetta package insert side effects related to AstraZeneca products by clicking here. Go to Healthcare Professional Site. Use of twice-daily exenatide in basal insulin—treated patients with type 2 diabetes: Go to Patient Site.
Staying Active Learn how regular physical activity can help you manage type 2 diabetes. Because exenatide is commonly associated with gastrointestinal adverse reactions, BYETTA is not recommended in patients with severe gastrointestinal disease eg gastroparesis. AstraZeneca provides this link as a service to website visitors. Not a substitute for insulin and should not be used in patients with type 1 diabetes or diabetic ketoacidosis.
Type 2 Diabetes Medication | BYETTA® (exenatide) injection
Tell your healthcare provider isnert you have severe problems with your stomach, byetta package insert as delayed emptying of your stomach gastroparesis or problems with digesting food. The most common side effects with BYETTA include nausea, vomiting, diarrhea, feeling jittery, dizziness, headache, acid stomach, constipation, and weakness.
You may give other people a serious infection, or get a serious byetta package insert from them. BYETTA should not be used in people with type 1 diabetes or people with diabetic ketoacidosis a condition caused by very high blood sugar. Signs and symptoms of low blood sugar may include headache, drowsiness, weakness, dizziness, confusion, irritability, hunger, fast heartbeat, sweating, and feeling jittery. Concurrent use with prandial insulin has not been studied and cannot be recommended.
The most frequently reported adverse reactions leading to withdrawal for Byetta-treated patients were nausea 5. Stop taking BYETTA and call your healthcare provider right away byetta package insert you have pain in your stomach area abdomen that is severe, and will not go away, occurs with or without vomiting or is felt going from your abdomen through to your back. You are encouraged to report negative side effects insertt prescription drugs to the FDA.
Add BYETTA to insulin glargine as a complementary action to help improve glycemic control
Increased risk of hypoglycemia when used in combination with a sulfonylurea SU or when used byetta package insert a glucose-independent insulin secretagogues eg, meglitinides. Based on postmarketing data BYETTA has been associated with acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis. Byetta package insert other trademarks are property of their respective owners. Postmarketing reports of increased international normalized ratio INR sometimes associated with bleeding with concomitant use of warfarin.
BYETTA is an injectable prescription medicine that may improve blood sugar glucose control in adults with type 2 diabetes, when used with diet and exercise.
If worsening of or failure to achieve adequate glycemic control occurs, consider alternative antidiabetic therapy. Patients may develop antibodies to exenatide.
byetta package insert After initiation and dose increases of BYETTA, observe patients carefully for pancreatitis including persistent severe abdominal pain, sometimes radiating to the back, with or without vomiting. Postmarketing reports of serious hypersensitivity reactions eg anaphylaxis and angioedema.
This site is intended for US Consumers. Symptoms of a severe allergic reaction include severe rash or itching, swelling of your face, lips, and throat that may cause difficulty breathing or swallowing, feeling faint or dizzy and very rapid heartbeat. Use with caution in patients with renal transplantation or when initiating beytta byetta package insert the dose in patients with moderate renal failure. No clinical studies establishing conclusive evidence of macrovascular risk reduction with BYETTA or any other antidiabetic drug.
It is unknown whether patients with a history of pancreatitis byetta package insert at increased risk for pancreatitis while using BYETTA; consider other antidiabetic therapies for these patients. Postmarketing reports of altered renal function, including increased serum creatinine, renal impairment, worsened chronic renal failure, and acute renal failure, sometimes requiring hemodialysis and kidney byetta package insert.
BYETTA has been associated with acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, based on postmarketing data. All other packzge are property of their respective owners.
Drug Interactions Oral Medications: Approved Uses BYETTA is an byetta package insert prescription medicine that may improve blood sugar byetta package insert control in adults with type 2 diabetes, when used with diet and exercise. Glucagon-like peptide-1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes. Pen-sharing poses a risk for transmission of inset pathogens, even if the needle is changed.
The Double B logo is a trademark of the AstraZeneca group of companies. This product information is intended for US Healthcare Professionals only. Byetra medications dependent byetta package insert threshold concentrations for efficacy, such as contraceptives or antibiotics, should be taken at least 1 hour before BYETTA. Tell your healthcare provider if you are pregnant or plan to become pregnant.
These may be byetta package insert of pancreatitis. To report drug exposure during pregnancy call BYETTA slows gastric emptying and can reduce the extent and rate of absorption of orally administered drugs.
Tell your healthcare provider if you have or had kidney problems or a kidney transplant. Should not be used in patients with severe renal impairment or end-stage renal disease. The site you are about to visit is maintained by a third party who is solely responsible for its contents.
If pancreatitis is suspected, BYETTA should be discontinued promptly and should not be restarted if pancreatitis is confirmed. Byetta package insert risk for getting low blood sugar hypoglycemia is higher if insery take BYETTA with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. BYETTA is indicated lnsert an byetta package insert to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Based on animal data, BYETTA may cause fetal harm and should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Write your html here